Literature DB >> 27655548

[Effect of triggering receptor expressed on myeloid cells 2 overexpression on airway inflammation and remodeling in mice with allergic asthma].

Zhen Wang1, Jing Wang, Wen Zhang.   

Abstract

OBJECTIVE: To investigate the effect of triggering receptor expressed on myeloid cells 2 (TREM-2) overexpression on airway inflammation and remodeling in mice with asthma.
METHODS: A total of 40 BALB/c mice were randomly divided into normal control, asthma, empty vector, and TREM-2 overexpression groups (n=10 each). Ovalbumin (OVA) sensitization and challenge were performed to establish the model of asthma. The mice in the control group were given normal saline, and those in the empty vector and TREM-2 overexpression groups were transfected with adenovirus vector and TREM-2 adenovirus, respectively. RT-PCR and Western blot were used to measure the expression of TREM-2, MMP-2, MMP-9, ADAM33, and ADAM8. Bronchoalveolar lavage fluid (BALF) was collected to perform cell counting and classification. ELISA was used to measure the total serum level of IgE and the levels of cytokines in BALF.
RESULTS: Compared with the control group, the asthma group showed significant reductions in the mRNA and protein expression of TREM-2 (P<0.05), a significantly increased level of Th2 cytokine (P<0.05), and significantly increased numbers of total cells and classified cells. Compared with the asthma group, the TREM-2 overexpression group showed a significantly reduced level of Th2 cytokine (P<0.05), a significantly reduced level of IgE (P<0.05), and significantly reduced numbers of total cells and classified cells (P<0.05), as well as significantly downregulated expression of the inflammatory factors and growth factors MMP-2, MMP-9, TGF-β1, ADAM8, and ADAM33 (P<0.05).
CONCLUSIONS: TREM-2 overexpression significantly alleviates airway inflammation and airway remodeling in mice with asthma and may become a potential target for the prevention and treatment of childhood asthma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655548      PMCID: PMC7389976     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  11 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Cytokine mRNA expression in patients with mild allergic asthma following low dose or cumulative dose allergen provocation.

Authors:  J Prieto; I Van Der Ploeg; A Roquet; D Gigliotti; B Dahlén; A Eklund; J Grunewald
Journal:  Clin Exp Allergy       Date:  2001-05       Impact factor: 5.018

3.  Regulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthma.

Authors:  Haihong Jiang; Yan Xie; Peter W Abel; Dennis W Wolff; Myron L Toews; Reynold A Panettieri; Thomas B Casale; Yaping Tu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 4.  Inflammation, inflammatory mediators, and mediator antagonists in asthma.

Authors:  S C Lazarus
Journal:  J Clin Pharmacol       Date:  1998-07       Impact factor: 3.126

5.  The effects of (±)-Praeruptorin A on airway inflammation, remodeling and transforming growth factor-β1/Smad signaling pathway in a murine model of allergic asthma.

Authors:  You-yi Xiong; Jun-song Wang; Fei-hua Wu; Juan Li; Ling-yi Kong
Journal:  Int Immunopharmacol       Date:  2012-09-11       Impact factor: 4.932

6.  A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.

Authors:  Joshua R Bleharski; Viviane Kiessler; Cecilia Buonsanti; Peter A Sieling; Steffen Stenger; Marco Colonna; Robert L Modlin
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

Review 7.  Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling.

Authors:  Y C Yang; N Zhang; K Van Crombruggen; G H Hu; S L Hong; C Bachert
Journal:  Allergy       Date:  2012-08-23       Impact factor: 13.146

Review 8.  ADAM8: a new therapeutic target for asthma.

Authors:  Martin D Knolle; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2009-05       Impact factor: 6.902

9.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.

Authors:  Paul Van Eerdewegh; Randall D Little; Josée Dupuis; Richard G Del Mastro; Kathy Falls; Jason Simon; Dana Torrey; Sunil Pandit; Joyce McKenny; Karen Braunschweiger; Alison Walsh; Ziying Liu; Brooke Hayward; Colleen Folz; Susan P Manning; Alicia Bawa; Lisa Saracino; Michelle Thackston; Youssef Benchekroun; Neva Capparell; Mei Wang; Ron Adair; Yun Feng; JoAnn Dubois; Michael G FitzGerald; Hui Huang; René Gibson; Kristina M Allen; Alex Pedan; Melvyn R Danzig; Shelby P Umland; Robert W Egan; Francis M Cuss; Steuart Rorke; Joanne B Clough; John W Holloway; Stephen T Holgate; Tim P Keith
Journal:  Nature       Date:  2002-07-10       Impact factor: 49.962

Review 10.  Pathology of asthma.

Authors:  Makoto Kudo; Yoshiaki Ishigatsubo; Ichiro Aoki
Journal:  Front Microbiol       Date:  2013-09-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.